Export

EN
FR
Oseltamivir
Essential medicine status
Section:
6. Anti-infective medicines 6.4. Antiviral medicines 6.4.3. Other antivirals
ATC codes: J05AH02
EMLc
Indication
Influenza due to identified seasonal influenza virus ICD11 code: 1E30
INN
Oseltamivir
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Additional notes
Severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients.
Formulations
Oral > Liquid: 6 mg per mL (as phosphate) powder for oral liquid (EMLc)
Oral > Solid: 30 mg capsule (as phosphate) ; 45 mg capsule (as phosphate) ; 75 mg capsule (as phosphate)
EML status history
First added in 2011 (TRS 965)
Changed in 2013 (TRS 985)
Changed in 2017 (TRS 1006)
Changed in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Oseltamivir
DrugBank
Oseltamivir
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of oseltamivir powder for oral liquid 6 mg/mL on the EMLc.